LAUREN DOUGLAS: Open Payments
NPI 1578187928 · WYOMISSING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$921 in 41 payments from 12 companies in 2025. Trend: 2023 $955 · 2024 $972 · 2025 $921
Food & beverage: $921
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 5 | $179 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $150 |
| AstraZeneca Pharmaceuticals LP | 8 | $142 |
| Fresenius USA Marketing, Inc. | 6 | $131 |
| Vifor Pharma, Inc. | 4 | $87 |
| Calliditas Therapeutics US Inc. | 2 | $65 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $55 |
| Otsuka America Pharmaceutical, Inc. | 1 | $30 |
| Mallinckrodt Hospital Products Inc. | 1 | $29 |
| Alexion Pharmaceuticals, Inc. | 1 | $19 |
Products named: JARDIANCE, VELPHORO, XPHOZAH 30 MG, LOKELMA, Veltassa, IBSRELA, TARPEYO, Kerendia.
Industry payments across PA — which companies pay providers there.
